The Physician Payment Sunshine Act (Open Payments), section 6002 of the Affordable Care Act, requires drug and device companies to publicly report to CMS payments and other transfers of value made to physicians, including podiatrists. The deadline for physicians to review data on payments and other transfers of value made to them by drug and device companies
APMA’s Health Policy and Practice department responded to a Senate Finance committee request for information on health care-related data. APMA asked for more detailed data on Medicare audits and appeals and increasingly specific goals for public transparency.
Find A Podiatrist
Contact us today to find out the answers to your questions.